{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T17:59:56Z","timestamp":1793555996530,"version":"4.5.0"},"reference-count":53,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Topical steroid withdrawal (TSW) is described as an adverse reaction to topical glucocorticoids (TGCs). A pathophysiological mechanism has not been identified. There are no diagnostic criteria. The aim was to describe patient-reported characteristics of TSW in atopic dermatitis (AD). An observational cross-sectional study was performed by posting a questionnaire for participants, aged \u226518 years, reporting both AD and TSW, in a Swedish TSW-themed Facebook group during 4 weeks in 2023. The questionnaire was accessed by 98 participants, with 82 completing it. Most were female (95%), 18\u201339 years old (74%), self-diagnosed with TSW (84%), and reported current symptoms of AD and TSW. They defined TSW as dependency on TGCs and adverse reactions to their use. Erythema, desquamation, dryness, and oozing affecting the face, neck, and upper extremities were the most reported signs. Pruritus, sleep disturbance, and signs of anxiety and depression were the most reported symptoms. Recurring episodes of manifestations attributed to TSW were reported by 60%. The personal trigger factor was believed to be TGCs by 93%, and 33% also identified oral glucocorticoids. TGCs were currently used by 21%. Self-reported manifestations of TSW are similar to those of AD but appeared to be distinguishable for the participants and caused considerable morbidity.<\/jats:p>","DOI":"10.2340\/actadv.v105.40187","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T08:46:57Z","timestamp":1735894017000},"page":"adv40187","source":"Crossref","is-referenced-by-count":11,"title":["Topical Steroid Withdrawal in Atopic Dermatitis: Patient-reported Characterization from a Swedish Social Media Questionnaire"],"prefix":"10.2340","volume":"105","author":[{"given":"Mikael","family":"Alsterholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Af Klinteberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vrang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnthorunn","family":"Sigurdardottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MariHelen","family":"Sandstr\u00f6m Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Shayesteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"89894","doi-asserted-by":"crossref","unstructured":"Hajar T, Leshem YA, Hanifin JM, Nedorost ST, Lio PA, Paller AS, et al. A systematic review of topical corticosteroid withdrawal (\"steroid addiction\") in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol 2015; 72: 541-549 e542.","DOI":"10.1016\/j.jaad.2014.11.024"},{"key":"89895","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2014.11.024","DOI":"10.1016\/j.jaad.2014.11.024"},{"key":"89896","unstructured":"Topical Steroid Withdrawal. British Association of Dermatologists, British Dermatological Nursing Group, National Eczema Society, 2024. Available from: https:\/\/cdn.bad.org.uk\/uploads\/2024\/02\/22095550\/Topical-Steroid-Withdrawal-Joint-Statement.pdf."},{"key":"89897","doi-asserted-by":"crossref","unstructured":"Bowe S, Masterson S, Murray G, Haugh I. Topical steroid withdrawal through the lens of social media. Clin Exp Dermatol 2022; 47: 1554-1557.","DOI":"10.1111\/ced.15194"},{"key":"89898","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ced.15194","DOI":"10.1111\/ced.15194"},{"key":"89899","doi-asserted-by":"crossref","unstructured":"Nickles MA, Coale AT, Henderson WJA, Brown KE, Morrell DS, Nieman EL. Steroid phobia on social media platforms. Pediatr Dermatol 2023; 40: 479-482.","DOI":"10.1111\/pde.15269"},{"key":"89900","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/pde.15269","DOI":"10.1111\/pde.15269"},{"key":"89901","doi-asserted-by":"crossref","unstructured":"Hwang J, Lio PA. Topical corticosteroid withdrawal ('steroid addiction'): an update of a systematic review. J Dermatolog Treat 2022; 33: 1293-1298.","DOI":"10.1080\/09546634.2021.1882659"},{"key":"89902","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/09546634.2021.1882659","DOI":"10.1080\/09546634.2021.1882659"},{"key":"89903","doi-asserted-by":"crossref","unstructured":"Barlow R, Proctor A, Moss C. Topical steroid withdrawal: a survey of UK dermatologists' attitudes. Clin Exp Dermatol 2024; 49: 607-611.","DOI":"10.1093\/ced\/llae045"},{"key":"89904","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/ced\/llae045","DOI":"10.1093\/ced\/llae045"},{"key":"89905","doi-asserted-by":"crossref","unstructured":"Cotter C, Burton T, Proctor A, Moss C, Flohr C. Topical steroid withdrawal syndrome: time to bridge the gap. Br J Dermatol 2022; 187: 780-781.","DOI":"10.1111\/bjd.21770"},{"key":"89906","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.21770","DOI":"10.1111\/bjd.21770"},{"key":"89907","doi-asserted-by":"crossref","unstructured":"Gust P, Jacob SE. The role of delayed-delayed corticosteroid contact dermatitis in topical steroid withdrawal. J Am Acad Dermatol 2016; 75: e167.","DOI":"10.1016\/j.jaad.2016.05.048"},{"key":"89908","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2016.05.048","DOI":"10.1016\/j.jaad.2016.05.048"},{"key":"89909","doi-asserted-by":"crossref","unstructured":"O'Connor C, Murphy M. Scratching the surface: a review of online misinformation and conspiracy theories in atopic dermatitis. Clin Exp Dermatol 2021; 46: 1545-1547.","DOI":"10.1111\/ced.14679"},{"key":"89910","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ced.14679","DOI":"10.1111\/ced.14679"},{"key":"89911","doi-asserted-by":"crossref","unstructured":"Finnegan P, Murphy M, O'Connor C. #corticophobia: a review on online misinformation related to topical steroids. Clin Exp Dermatol 2023; 48: 112-115.","DOI":"10.1093\/ced\/llac019"},{"key":"89912","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/ced\/llac019","DOI":"10.1093\/ced\/llac019"},{"key":"89913","doi-asserted-by":"crossref","unstructured":"Tan SY, Chandran NS, Choi EC. Steroid phobia: Is there a basis? A review of topical steroid safety, addiction and withdrawal. Clin Drug Investig 2021; 41: 835-842.","DOI":"10.1007\/s40261-021-01072-z"},{"key":"89914","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40261-021-01072-z","DOI":"10.1007\/s40261-021-01072-z"},{"key":"89915","doi-asserted-by":"crossref","unstructured":"Tan S, Phan P, Law JY, Choi E, Chandran NS. Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients. BMJ Open 2022; 12: e060867.","DOI":"10.1136\/bmjopen-2022-060867"},{"key":"89916","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmjopen-2022-060867","DOI":"10.1136\/bmjopen-2022-060867"},{"key":"89917","doi-asserted-by":"crossref","unstructured":"Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers 2018; 4: 1.","DOI":"10.1038\/s41572-018-0001-z"},{"key":"89918","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41572-018-0001-z","DOI":"10.1038\/s41572-018-0001-z"},{"key":"89919","doi-asserted-by":"crossref","unstructured":"Waclawski E. How I use it: Survey Monkey. Occup Med (Lond) 2012; 62: 477.","DOI":"10.1093\/occmed\/kqs075"},{"key":"89920","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/occmed\/kqs075","DOI":"10.1093\/occmed\/kqs075"},{"key":"89921","doi-asserted-by":"crossref","unstructured":"Alsterholm M, Svedbom A, Anderson CD, Holm Sommar L, Ivert LU, Josefson A, et al. Establishment and utility of SwedAD: a nationwide Swedish registry for patients with atopic dermatitis receiving systemic pharmacotherapy. Acta Derm Venereol 2023; 103: adv7312.","DOI":"10.2340\/actadv.v103.7312"},{"key":"89922","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/actadv.v103.7312","DOI":"10.2340\/actadv.v103.7312"},{"key":"89923","doi-asserted-by":"crossref","unstructured":"Byrom B, Elash CA, Eremenco S, Bodart S, Muehlhausen W, Platko JV, et al. Measurement comparability of electronic and paper administration of visual analogue scales: a review of published studies. Ther Innov Regul Sci 2022; 56: 394-404.","DOI":"10.1007\/s43441-022-00376-2"},{"key":"89924","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s43441-022-00376-2","DOI":"10.1007\/s43441-022-00376-2"},{"key":"89925","doi-asserted-by":"crossref","unstructured":"Baltar F, Brunet I. Social research 2.0: virtual snowball sampling method using Facebook. Internet Res 2012; 22: 57-74.","DOI":"10.1108\/10662241211199960"},{"key":"89926","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1108\/10662241211199960","DOI":"10.1108\/10662241211199960"},{"key":"89927","doi-asserted-by":"crossref","unstructured":"Ferrario B, Stantcheva S. Eliciting people's first-order concerns: text analysis of open-ended survey questions. AEA Papers and Proceedings 2022; 112: 163-169.","DOI":"10.1257\/pandp.20221071"},{"key":"89928","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1257\/pandp.20221071","DOI":"10.1257\/pandp.20221071"},{"key":"89929","doi-asserted-by":"crossref","unstructured":"Hulsen T, de Vlieg J, Alkema W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 2008; 9: 488.","DOI":"10.1186\/1471-2164-9-488"},{"key":"89930","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/1471-2164-9-488","DOI":"10.1186\/1471-2164-9-488"},{"key":"89931","doi-asserted-by":"crossref","unstructured":"Whitaker C, Stevelink S, Fear N. The use of Facebook in recruiting participants for health research purposes: a systematic review. J Med Internet Res 2017; 19: e290.","DOI":"10.2196\/jmir.7071"},{"key":"89932","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2196\/jmir.7071","DOI":"10.2196\/jmir.7071"},{"key":"89933","doi-asserted-by":"crossref","unstructured":"Browne K. Snowball sampling: using social networks to research non\u2010heterosexual women. Int J Social Research Methodology 2005; 8: 47-60.","DOI":"10.1080\/1364557032000081663"},{"key":"89934","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/1364557032000081663","DOI":"10.1080\/1364557032000081663"},{"key":"89935","doi-asserted-by":"crossref","unstructured":"Sheary B. Steroid withdrawal effects following long-term topical corticosteroid use. Dermatitis 2018; 29: 213-218.","DOI":"10.1097\/DER.0000000000000387"},{"key":"89936","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/DER.0000000000000387","DOI":"10.1097\/DER.0000000000000387"},{"key":"89937","doi-asserted-by":"crossref","unstructured":"Sheary B, Harris MF. Cessation of long-term topical steroids in adult atopic dermatitis: a prospective cohort study. Dermatitis 2020; 31: 316-320.","DOI":"10.1097\/DER.0000000000000602"},{"key":"89938","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/DER.0000000000000602","DOI":"10.1097\/DER.0000000000000602"},{"key":"89939","doi-asserted-by":"crossref","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020; 396: 345-360.","DOI":"10.1016\/S0140-6736(20)31286-1"},{"key":"89940","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(20)31286-1","DOI":"10.1016\/S0140-6736(20)31286-1"},{"key":"89941","doi-asserted-by":"crossref","unstructured":"Arnold KA, Treister AD, Lio PA. Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: a retrospective case series. JAAD Case Rep 2018; 4: 860-862.","DOI":"10.1016\/j.jdcr.2018.06.012"},{"key":"89942","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jdcr.2018.06.012","DOI":"10.1016\/j.jdcr.2018.06.012"},{"key":"89943","doi-asserted-by":"crossref","unstructured":"Barta K, Fonacier LS, Hart M, Lio P, Tullos K, Sheary B, et al. Corticosteroid exposure and cumulative effects in patients with eczema: results from a patient survey. Ann Allergy Asthma Immunol 2023; 130: 93-99 e10.","DOI":"10.1016\/j.anai.2022.09.031"},{"key":"89944","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.anai.2022.09.031","DOI":"10.1016\/j.anai.2022.09.031"},{"key":"89945","doi-asserted-by":"crossref","unstructured":"Spergel JM, Leung DYM. Topical steroid withdrawal syndrome: should we worry? Ann Allergy Asthma Immunol 2023; 130: 8.","DOI":"10.1016\/j.anai.2022.09.005"},{"key":"89946","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.anai.2022.09.005","DOI":"10.1016\/j.anai.2022.09.005"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40187\/48522","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40187\/48522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T08:47:56Z","timestamp":1735894076000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/40187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":53,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.40187","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}